Financial Ratios Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-09			5-day change	1st Jan Change
31.59 ^CNY	+1.31%		+11.12%	+11.12%

Dec. 18	Pharmaron Beijing Co., Ltd. Announces Election of Mr. Li Shing Chung Gilbert as Employee Representative Director Effective December 18, 2025	CI
25-10-28	Pharmaron Beijing Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

a2.oTaJRW2v5Bp2utpOPMLY85xTRJorVKRIzYgGUMH31Rc.xVG8GiPdh2BP74h5ZKyensYUC6lvEdwigvJjHaCGt3bofMEsWeTJchOLgw

Published financial data: PHARMARON BEIJING CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.11B	7.42B	10.24B	11.53B	12.27B
Other Revenues, Total	19.55M	24.48M	26.19M	4.61M	6.4M
Total Revenues	5.13B	7.44B	10.27B	11.54B	12.28B
Cost of Goods Sold, Total	3.21B	4.77B	6.5B	7.42B	8.09B
Gross Profit	1.92B	2.68B	3.76B	4.12B	4.18B
Selling General & Admin Expenses, Total	746M	1.02B	1.73B	1.86B	1.84B
Provision for Bad Debts	14.82M	10.27M	21.16M	35.83M	42.95M
R&D Expenses	105M	152M	282M	448M	469M
Other Operating Expenses	32.9M	44.04M	66.52M	82.75M	110M
Other Operating Expenses, Total	899M	1.23B	2.1B	2.43B	2.47B
Operating Income	1.02B	1.45B	1.67B	1.69B	1.72B
Interest Expense, Total	-23.85M	-83.07M	-167M	-182M	-244M
Interest And Investment Income	232M	372M	110M	78.95M	616M
Net Interest Expenses	208M	289M	-57.57M	-103M	372M
Currency Exchange Gains (Loss)	-131M	-3.16M	-42.39M	147M	31.43M
Other Non Operating Income (Expenses)	-1.35M	-1.39M	-2.54M	-3.61M	-4.22M
EBT, Excl. Unusual Items	1.1B	1.73B	1.56B	1.73B	2.12B
Impairment of Goodwill	-	-	-	-	-73.54M
Gain (Loss) On Sale Of Investments	191M	120M	68.09M	18.75M	1.54M
Gain (Loss) On Sale Of Assets	-7.28M	-1.37M	-15.3M	-9.15M	-33.67M
Asset Writedown	-	-	-	-	-
Other Unusual Items	40.72M	60.84M	49.5M	98.48M	78.51M
EBT, Incl. Unusual Items	1.32B	1.91B	1.67B	1.84B	2.09B
Income Tax Expense	172M	291M	314M	256M	377M
Earnings From Continuing Operations	1.15B	1.62B	1.35B	1.58B	1.71B
Net Income to Company	1.15B	1.62B	1.35B	1.58B	1.71B
Minority Interest	25.39M	40.95M	22.47M	19.32M	79.19M
Net Income - (IS)	1.17B	1.66B	1.37B	1.6B	1.79B
Net Income to Common Incl Extra Items	1.17B	1.66B	1.37B	1.6B	1.79B
Net Income to Common Excl. Extra Items	1.17B	1.66B	1.37B	1.6B	1.79B
Per Share Items
Net EPS - Basic	0.66	0.93	0.78	0.9	1.01
Basic EPS - Continuing Operations	0.66	0.93	0.78	0.9	1.01
Basic Weighted Average Shares Outstanding	1.78B	1.78B	1.77B	1.77B	1.77B
Net EPS - Diluted	0.66	0.91	0.77	0.9	1.01
Diluted EPS - Continuing Operations	0.66	0.91	0.77	0.9	1.01
Diluted Weighted Average Shares Outstanding	1.78B	1.82B	1.78B	1.78B	1.77B
Normalized Basic EPS	0.4	0.63	0.56	0.62	0.79
Normalized Diluted EPS	0.4	0.62	0.56	0.62	0.79
Dividend Per Share	0.13	0.2	0.2	0.2	0.2
Payout Ratio	11.55	17.14	29.45	27.78	30.24
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.32B	1.85B	2.22B	2.42B	2.58B
EBITA	1.03B	1.47B	1.7B	1.72B	1.75B
EBIT	1.02B	1.45B	1.67B	1.69B	1.72B
EBITDAR	1.33B	1.85B	2.23B	2.43B	2.59B
Total Revenues (As Reported)	5.13B	7.44B	10.27B	11.54B	12.28B
Effective Tax Rate - (Ratio)	13.07	15.22	18.86	13.93	18.03
Total Current Taxes	144M	282M	293M	320M	410M
Total Deferred Taxes	28.44M	8.82M	20.96M	-63.63M	-33.34M
Normalized Net Income	710M	1.12B	1B	1.1B	1.4B
Interest Capitalized	4.66M	34.67M	24.39M	31.31M	17.62M
Interest on Long-Term Debt	-	48.7M	55.75M	185M	45.41M
Supplemental Operating Expense Items
Selling and Marketing Expenses	92.64M	156M	230M	253M	258M
General and Administrative Expenses	653M	867M	1.5B	1.61B	1.58B
Research And Development Expense From Footnotes	105M	152M	282M	448M	469M
Net Rental Expense, Total	7.25M	8.2M	8.72M	8.94M	8.94M
Imputed Operating Lease Interest Expense	1.58M	2.44M	2.35M	1.93M	2.39M
Imputed Operating Lease Depreciation	5.67M	5.76M	6.37M	7.01M	6.56M
Stock-Based Comp., G&A Exp. (Total)	62.46M	67.53M	177M	202M	91.11M
Total Stock-Based Compensation	62.46M	67.53M	177M	202M	91.11M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.94B	3.54B	1.5B	5.92B	1.69B
Short Term Investments	-	1.08B	613M	179M	257M
Trading Asset Securities, Total	910M	1.55B	745M	622M	1.12B
Total Cash And Short Term Investments	3.85B	6.18B	2.86B	6.72B	3.07B
Accounts Receivable, Total	1.21B	1.42B	2.21B	2.64B	2.87B
Other Receivables	33.38M	92.43M	71.16M	80.98M	127M
Notes Receivable	-	3.36M	-	-	-
Total Receivables	1.24B	1.52B	2.29B	2.72B	3B
Inventory	282M	680M	1.04B	1.01B	1.12B
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	163M	266M	353M	424M	426M
Total Current Assets	5.54B	8.64B	6.54B	10.87B	7.61B
Gross Property Plant And Equipment	5.14B	7.48B	10.63B	13.07B	14.65B
Accumulated Depreciation	-1.34B	-1.67B	-2.16B	-3.01B	-3.86B
Net Property Plant And Equipment	3.8B	5.81B	8.46B	10.06B	10.8B
Long-term Investments	402M	763M	1.01B	1B	883M
Goodwill	1.17B	2.1B	2.69B	2.78B	2.76B
Other Intangibles, Total	566M	693M	803M	789M	791M
Loans Receivable Long-Term	109K	-	-	-	23.71M
Deferred Tax Assets Long-Term	8.44M	15.6M	58.79M	153M	193M
Deferred Charges Long-Term	234M	172M	496M	520M	679M
Other Long-Term Assets, Total	193M	196M	439M	291M	192M
Total Assets	11.91B	18.39B	20.49B	26.48B	23.93B
Liabilities
Accounts Payable, Total	191M	316M	406M	412M	477M
Accrued Expenses, Total	472M	626M	785M	806M	854M
Short-term Borrowings	377M	422M	663M	577M	765M
Current Portion of Long-Term Debt	8.88M	60.54M	74.94M	150M	282M
Current Portion of Leases	83.92M	95.29M	164M	185M	150M
Current Income Taxes Payable	27.62M	81.34M	146M	185M	160M
Unearned Revenue Current, Total	473M	680M	832M	741M	835M
Other Current Liabilities	347M	702M	841M	598M	701M
Total Current Liabilities	1.98B	2.98B	3.91B	3.65B	4.22B
Long-Term Debt	395M	4.42B	4.45B	8.2B	4.38B
Long-Term Leases	187M	284M	761M	585M	401M
Unearned Revenue Non Current	158M	149M	152M	392M	410M
Deferred Tax Liability Non Current	107M	173M	261M	290M	292M
Other Non Current Liabilities	147M	81.56M	112M	118M	-
Total Liabilities	2.98B	8.09B	9.65B	13.24B	9.7B
Common Stock, Total	794M	794M	1.19B	1.79B	1.78B
Additional Paid In Capital	6.03B	6.01B	5.25B	5.22B	5.01B
Retained Earnings	2.13B	3.55B	4.57B	5.82B	7.26B
Treasury Stock	-45.47M	-302M	-668M	-463M	-416M
Comprehensive Income and Other	-38.22M	74.15M	197M	194M	-7.76M
Total Common Equity	8.87B	10.13B	10.55B	12.56B	13.62B
Minority Interest	63.42M	166M	291M	681M	604M
Total Equity	8.93B	10.3B	10.84B	13.24B	14.22B
Total Liabilities And Equity	11.91B	18.39B	20.49B	26.48B	23.93B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.79B	1.79B	1.79B	1.79B	1.77B
ECS Total Common Shares Outstanding	1.79B	1.79B	1.79B	1.79B	1.77B
Book Value / Share	4.96	5.67	5.9	7.03	7.71
Tangible Book Value	7.14B	7.34B	7.06B	8.99B	10.07B
Tangible Book Value Per Share	3.99	4.11	3.95	5.03	5.7
Total Debt	1.05B	5.29B	6.12B	9.7B	5.98B
Net Debt	-2.8B	-893M	3.26B	2.98B	2.91B
Debt Equivalent Oper. Leases	58.02M	65.62M	69.76M	71.49M	71.56M
Minority Interest, Total (Incl. Fin. Div)	63.42M	166M	291M	681M	604M
Equity Method Investments, Total	280M	453M	630M	723M	649M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	124M	497M	379M	391M	950M
Inventories - Work In Process, Total	153M	166M	183M	156M	212M
Inventories - Finished Goods, Total	-	-	497M	492M	-
Inventories - Others	15.71M	30.84M	-	-	-
Buildings, Total	1.67B	2.47B	3.35B	3.97B	4.92B
Machinery, Total	2.19B	2.92B	4.26B	5.15B	6.27B
Full Time Employees	11.01K	14.92K	19.48K	20.3K	21.37K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	34.11M	38.49M	57.64M	74.46M	83.51M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.17B	1.66B	1.37B	1.6B	1.79B
Depreciation & Amortization - CF	357M	465M	656M	883M	1B
Amortization of Goodwill and Intangible Assets - (CF)	13.34M	26.77M	33.48M	33.76M	33.86M
Depreciation & Amortization, Total	370M	492M	689M	916M	1.03B
Amortization of Deferred Charges, Total - (CF)	67.74M	85.81M	76.71M	81.42M	112M
(Gain) Loss From Sale Of Asset	7.28M	1.37M	1.21M	10.73M	25.38M
(Gain) Loss on Sale of Investments - (CF)	-348M	-285M	71.84M	-21.01M	-545M
Asset Writedown & Restructuring Costs	19.45M	-55.91M	-221M	-3.64M	76.56M
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-	-	-	-	42.95M
Other Operating Activities, Total	62.79M	-38.39M	319M	-33.69M	97.19M
Change In Accounts Receivable	-95.35M	-296M	-831M	-480M	-297M
Change In Inventories	-120M	-225M	-121M	82.43M	-148M
Change In Accounts Payable	422M	642M	584M	461M	328M
Change In Deferred Taxes	28.44M	8.82M	20.96M	-63.63M	-33.34M
Change in Other Net Operating Assets	62.46M	67.53M	177M	202M	91.11M
Cash from Operations	1.65B	2.06B	2.14B	2.75B	2.58B
Capital Expenditure	-1.32B	-2.09B	-2.95B	-2.87B	-2.04B
Sale of Property, Plant, and Equipment	3.21M	1.61M	3.15M	8.11M	3.32M
Cash Acquisitions	-792M	-1.23B	-1.02B	-	-22.63M
Investment in Marketable and Equity Securities, Total	-1.27B	-2.02B	1.7B	558M	-676M
Other Investing Activities, Total	2.94M	78.79M	61.13M	48.81M	711M
Cash from Investing	-3.37B	-5.26B	-2.21B	-2.25B	-2.02B
Long-Term Debt Issued, Total	733M	4.62B	590M	4.17B	1.32B
Total Debt Issued	733M	4.62B	590M	4.17B	1.32B
Long-Term Debt Repaid, Total	-761M	-300M	-839M	-767M	-5.3B
Total Debt Repaid	-761M	-300M	-839M	-767M	-5.3B
Issuance of Common Stock	-	-	-	17.33M	10.51M
Repurchase of Common Stock	-	-284M	-393M	-830K	-286M
Common Dividends Paid	-135M	-285M	-405M	-445M	-542M
Common & Preferred Stock Dividends Paid	-135M	-285M	-405M	-445M	-542M
Other Financing Activities, Total	-116M	-91.26M	-370M	940M	-5.8M
Cash from Financing	-280M	3.66B	-1.42B	3.92B	-4.8B
Foreign Exchange Rate Adjustments	-85.67M	-45.52M	72.99M	11.43M	78.14M
Net Change in Cash	-2.09B	416M	-1.41B	4.43B	-4.17B
Supplemental Items
Cash Income Tax Paid (Refund)	-34.28M	-22M	-235M	-54.99M	111M
Levered Free Cash Flow	27.17M	-479M	-1.68B	-1.47B	17.01M
Unlevered Free Cash Flow	42.08M	-428M	-1.57B	-1.35B	169M
Change In Net Working Capital	-220M	-115M	608M	743M	101M
Net Debt Issued / Repaid	-28.46M	4.32B	-249M	3.4B	-3.97B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	5.84	5.97	5.36	4.5	4.26
Return on Total Capital	6.76	7.08	6.4	5.29	4.98
Return On Equity %	13.68	16.85	12.8	13.14	12.48
Return on Common Equity	14.09	17.48	13.3	13.86	13.7
Margin Analysis
Gross Profit Margin %	37.38	35.95	36.67	35.67	34.09
SG&A Margin	14.53	13.74	16.83	16.12	15.02
EBITDA Margin %	25.71	24.8	21.63	20.97	21.04
EBITA Margin %	20.13	19.81	16.56	14.94	14.28
EBIT Margin %	19.87	19.45	16.23	14.64	14.01
Income From Continuing Operations Margin %	22.34	21.76	13.17	13.71	13.96
Net Income Margin %	22.84	22.31	13.39	13.88	14.61
Net Avail. For Common Margin %	22.84	22.31	13.39	13.88	14.61
Normalized Net Income Margin	13.83	15.09	9.74	9.54	11.43
Levered Free Cash Flow Margin	0.53	-6.44	-16.34	-12.71	0.14
Unlevered Free Cash Flow Margin	0.82	-5.74	-15.32	-11.72	1.38
Asset Turnover
Asset Turnover	0.47	0.49	0.53	0.49	0.49
Fixed Assets Turnover	1.54	1.55	1.44	1.25	1.18
Receivables Turnover (Average Receivables)	4.74	5.63	5.63	4.76	4.46
Inventory Turnover (Average Inventory)	14.65	9.92	7.55	7.23	7.6
Short Term Liquidity
Current Ratio	2.8	2.9	1.67	2.98	1.8
Quick Ratio	2.57	2.58	1.31	2.58	1.44
Operating Cash Flow to Current Liabilities	0.83	0.69	0.55	0.75	0.61
Days Sales Outstanding (Average Receivables)	77.17	64.8	64.84	76.76	82.15
Days Outstanding Inventory (Average Inventory)	24.99	36.81	48.32	50.52	48.17
Average Days Payable Outstanding	16.96	17.91	19.2	20.2	19.86
Cash Conversion Cycle (Average Days)	85.2	83.7	93.97	107.07	110.46
Long Term Solvency
Total Debt/Equity	11.77	51.34	56.43	73.26	42.01
Total Debt / Total Capital	10.53	33.92	36.07	42.28	29.58
LT Debt/Equity	6.51	45.72	48.11	66.36	33.6
Long-Term Debt / Total Capital	5.82	30.21	30.75	38.3	23.66
Total Liabilities / Total Assets	24.98	44.01	47.1	50	40.56
EBIT / Interest Expense	42.76	17.43	9.96	9.27	7.05
EBITDA / Interest Expense	58.28	23.35	14.08	14.3	11.3
(EBITDA - Capex) / Interest Expense	3.12	-1.85	-3.55	-1.42	2.92
Total Debt / EBITDA	0.76	2.73	2.6	3.72	2.17
Net Debt / EBITDA	-2.01	-0.46	1.38	1.14	1.06
Total Debt / (EBITDA - Capex)	14.14	-34.46	-10.3	-37.4	8.39
Net Debt / (EBITDA - Capex)	-37.65	5.82	-5.49	-11.48	4.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	36.64	45	37.92	12.39	6.39
Gross Profit, 1 Yr. Growth %	43.92	39.46	40.67	9.34	1.66
EBITDA, 1 Yr. Growth %	42.23	39.35	19.89	8.65	6.24
EBITA, 1 Yr. Growth %	52.64	42.01	14.84	0.97	1.09
EBIT, 1 Yr. Growth %	53.34	41.92	15.13	1.38	1.75
Earnings From Cont. Operations, 1 Yr. Growth %	116.14	41.25	-16.54	16.98	8.37
Net Income, 1 Yr. Growth %	114.25	41.68	-17.24	16.48	12.01
Normalized Net Income, 1 Yr. Growth %	83.36	58.27	-10.98	10.04	27.51
Diluted EPS Before Extra, 1 Yr. Growth %	78.46	38.96	-15.21	16.54	12.13
Accounts Receivable, 1 Yr. Growth %	27.92	17.64	55.53	19.05	8.91
Inventory, 1 Yr. Growth %	78.92	141.48	53.15	-2.73	10.22
Net Property, Plant and Equip., 1 Yr. Growth %	31.79	52.96	45.66	18.89	7.31
Total Assets, 1 Yr. Growth %	19.87	54.42	11.44	29.2	-9.63
Tangible Book Value, 1 Yr. Growth %	-0.07	2.83	-3.84	27.32	12.03
Common Equity, 1 Yr. Growth %	14.2	14.19	4.14	19.04	8.46
Cash From Operations, 1 Yr. Growth %	75.65	24.84	4.12	28.5	-6.42
Capital Expenditures, 1 Yr. Growth %	74.37	59.05	40.95	-2.87	-28.78
Levered Free Cash Flow, 1 Yr. Growth %	-117.06	-1.86K	249.95	-12.61	-101.17
Unlevered Free Cash Flow, 1 Yr. Growth %	-139.08	-1.12K	267.99	-14.04	-112.62
Dividend Per Share, 1 Yr. Growth %	99.85	50.04	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	32.86	40.76	41.42	24.5	9.35
Gross Profit, 2 Yr. CAGR %	42.12	41.67	40.06	24.02	5.43
EBITDA, 2 Yr. CAGR %	43.5	41.04	29.47	14.31	7.68
EBITA, 2 Yr. CAGR %	53.53	47.58	27.97	7.9	1.34
EBIT, 2 Yr. CAGR %	53.87	47.52	27.83	8.04	1.57
Earnings From Cont. Operations, 2 Yr. CAGR %	85.63	74.72	8.58	-1.19	12.59
Net Income, 2 Yr. CAGR %	87.62	74.23	8.28	-1.82	14.22
Normalized Net Income, 2 Yr. CAGR %	73.39	70.35	18.7	-1.03	18.46
Diluted EPS Before Extra, 2 Yr. CAGR %	61.9	57.47	8.54	-0.59	14.31
Accounts Receivable, 2 Yr. CAGR %	35.9	22.67	35.26	36.07	13.87
Inventory, 2 Yr. CAGR %	52.9	107.86	92.31	22.05	3.55
Net Property, Plant and Equip., 2 Yr. CAGR %	21.93	41.98	49.27	31.6	12.95
Total Assets, 2 Yr. CAGR %	57.49	36.05	31.18	19.99	8.06
Tangible Book Value, 2 Yr. CAGR %	100.09	1.37	-0.56	10.65	19.43
Common Equity, 2 Yr. CAGR %	95.85	14.2	9.05	11.34	13.63
Cash From Operations, 2 Yr. CAGR %	44.39	48.08	14.01	15.67	9.66
Capital Expenditures, 2 Yr. CAGR %	43.28	66.54	49.73	17.01	-16.83
Levered Free Cash Flow, 2 Yr. CAGR %	-22.54	73.53	685.85	74.88	-89.93
Unlevered Free Cash Flow, 2 Yr. CAGR %	160.69	99.26	511.47	77.86	-67.19
Dividend Per Share, 2 Yr. CAGR %	65.11	73.16	22.49	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	30.8	36.79	39.8	30.99	18.15
Gross Profit, 3 Yr. CAGR %	35.43	41.23	41.34	28.96	16.07
EBITDA, 3 Yr. CAGR %	37.81	42.28	33.75	22.24	11.72
EBITA, 3 Yr. CAGR %	41.48	49.82	35.93	18.41	5.8
EBIT, 3 Yr. CAGR %	41.54	49.78	35.82	18.32	5.9
Earnings From Cont. Operations, 3 Yr. CAGR %	71.59	69.47	36.58	11.31	1.9
Net Income, 3 Yr. CAGR %	71.89	70.85	35.94	10.95	2.59
Normalized Net Income, 3 Yr. CAGR %	61.4	68.2	37.21	15.74	7.69
Diluted EPS Before Extra, 3 Yr. CAGR %	55.92	53.86	28.11	11.14	3.48
Accounts Receivable, 3 Yr. CAGR %	30.67	29.51	32.77	29.63	26.34
Inventory, 3 Yr. CAGR %	44.54	78.06	87.74	53.22	17.98
Net Property, Plant and Equip., 3 Yr. CAGR %	21.96	31.5	43.2	38.36	22.94
Total Assets, 3 Yr. CAGR %	44.84	56.46	27.29	30.52	9.17
Tangible Book Value, 3 Yr. CAGR %	65.94	60.27	-0.4	7.98	11.11
Common Equity, 3 Yr. CAGR %	64.36	63.61	10.74	12.28	10.37
Cash From Operations, 3 Yr. CAGR %	43.99	37.55	31.68	18.65	7.78
Capital Expenditures, 3 Yr. CAGR %	12.08	48.35	57.53	29.62	-0.84
Levered Free Cash Flow, 3 Yr. CAGR %	-63.96	119.58	119.24	277.9	-67.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	-57.36	310.26	144.47	217.95	-26.56
Dividend Per Share, 3 Yr. CAGR %	-	59.92	44.2	14.48	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	35.4	35.42	34.95	31.74	26.72
Gross Profit, 5 Yr. CAGR %	43.95	41.36	37.27	34.08	25.7
EBITDA, 5 Yr. CAGR %	54.67	45.73	34.51	30.44	22.72
EBITA, 5 Yr. CAGR %	64.22	50.79	36.04	31.49	20.96
EBIT, 5 Yr. CAGR %	64.21	50.42	35.89	31.43	20.92
Earnings From Cont. Operations, 5 Yr. CAGR %	73.08	55.72	42.89	36.58	26.43
Net Income, 5 Yr. CAGR %	73.84	56.5	42.88	36.89	26.8
Normalized Net Income, 5 Yr. CAGR %	70.72	55.64	42.73	36.05	29.38
Diluted EPS Before Extra, 5 Yr. CAGR %	21.26	42.45	34.89	29.19	22.4
Accounts Receivable, 5 Yr. CAGR %	37.17	29.5	32.49	32.1	24.86
Inventory, 5 Yr. CAGR %	42.59	49.01	62.03	53.09	47.97
Net Property, Plant and Equip., 5 Yr. CAGR %	49.93	50.93	32.22	31.54	30.23
Total Assets, 5 Yr. CAGR %	58.93	45.66	39.21	40.7	19.22
Tangible Book Value, 5 Yr. CAGR %	117.42	33.34	35.21	38.2	7.1
Common Equity, 5 Yr. CAGR %	120.95	41.85	39.49	40.27	11.89
Cash From Operations, 5 Yr. CAGR %	50.02	54.24	31.15	28.34	22.38
Capital Expenditures, 5 Yr. CAGR %	38.49	14.67	25.84	34.92	22.01
Levered Free Cash Flow, 5 Yr. CAGR %	-33.98	-20.23	23.65	100.47	-36.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	-28.63	-21.92	23.72	193.67	9.48
Dividend Per Share, 5 Yr. CAGR %	-	-	-	32.54	24.56